ID   TR9-7
AC   CVCL_IM77
SY   Tr9-7
DR   GEO; GSE7101
DR   Wikidata; Q54972936
RX   PubMed=7667317;
RX   PubMed=16966095;
CC   Characteristics: Expresses wild-type TP53 under the control of a tetracycline-regulated promoter.
CC   Transfected with: HGNC; 11998; TP53.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Omics: Transcriptome analysis by microarray.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E212 ! MDAH041
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 7
//
RX   PubMed=7667317; DOI=10.1073/pnas.92.18.8493;
RA   Agarwal M.L., Agarwal A., Taylor W.R., Stark G.R.;
RT   "p53 controls both the G2/M and the G1 cell cycle checkpoints and
RT   mediates reversible growth arrest in human fibroblasts.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8493-8497(1995).
//
RX   PubMed=16966095; DOI=10.1289/ehp.8969;
RA   McNeely S.C., Xu X.-G., Taylor B.F., Zacharias W., McCabe M.J. Jr.,
RA   States J.C.;
RT   "Exit from arsenite-induced mitotic arrest is p53 dependent.";
RL   Environ. Health Perspect. 114:1401-1406(2006).
//